Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

142
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
142
Skin Cancer01:30

Skin Cancer

3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathological Characterization of Digital Papillary Adenocarcinoma With Emphasis on Low-risk Human Papillomavirus In Situ Hybridization and BRAF-VE1 Immunohistochemistry.

The American journal of surgical pathology·2026
Same author

Optimising Melanoma Diagnostic Accuracy in Specialised Pigmented Lesion Clinics: A Five-Year Audit of Number Needed to Treat.

The Australasian journal of dermatology·2026
Same author

Clinical, Imaging, Pathological, and Molecular Details of an Unusual Uveal Melanocytic Tumor of Childhood.

Ocular oncology and pathology·2026
Same author

Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma.

medRxiv : the preprint server for health sciences·2026
Same author

TFG-Containing Fusions in Melanocytic Tumors: From Polymorphic Read-Through Transcripts to Oncogenic Kinase Fusions.

Journal of cutaneous pathology·2026
Same author

Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous Tumors.

The American journal of surgical pathology·2026

Related Experiment Video

Updated: Jun 3, 2025

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

13.6K

Sex differences in melanoma survival-a GEM study.

Tharani Murali1, Matthew Schwartz2, Adam Z Reynolds3

  • 1Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, NM 87131, United States.

JNCI Cancer Spectrum
|January 12, 2025
PubMed
Summary

Female patients have a better survival rate for melanoma. This survival advantage is primarily due to differences in tumor characteristics at diagnosis, not sex itself.

More Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.6K

Related Experiment Videos

Last Updated: Jun 3, 2025

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

13.6K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.6K

Area of Science:

  • Oncology
  • Dermatology
  • Epidemiology

Background:

  • Sex differences in melanoma incidence and outcomes are well-documented.
  • Females exhibit a significant survival advantage in melanoma compared to males.
  • The underlying reasons for this female survival advantage remain largely unexplained.

Purpose of the Study:

  • To investigate the relationship between sex, clinicopathologic variables, and melanoma-specific survival.
  • To determine the extent to which clinicopathologic features mediate the observed sex differences in survival.

Main Methods:

  • Analysis of 1753 single primary melanomas from the Genes, Environment, and Melanoma (GEM) study.
  • Utilized Cox proportional hazard models and formal mediation analysis.
  • Examined the influence of age at diagnosis, Breslow thickness, ulceration, mitoses, and tumor site.

Main Results:

  • Clinicopathologic features at diagnosis largely explain the effect of sex on melanoma survival.
  • 86.5% of the sex effect on survival is mediated by differences in age, thickness, ulceration, mitoses, and site (HR = 1.85, P < .001).
  • The direct effect of sex on survival was not significant (HR = 1.19, P = .42).

Conclusions:

  • The female survival advantage in melanoma is predominantly an indirect effect.
  • This advantage is mediated by favorable differences in tumor characteristics observed at diagnosis in females.
  • Clinical management and research should consider these sex-mediated differences in tumor biology and presentation.